Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Naltrexone × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Other 1 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Overweight 1 Obesity 1 Breast Neoplasms 1

Interventions

naloxegol 7 Radiotherapy 6 Metformin 5 Exenatide 4 Cisplatin 4 Surveys and Questionnaires 3 Water 2 Vitamin D 2 Therapeutics 2 Testosterone 2 Sugars 2 Radiation 2 Methods 2 Injections 2 Dexamethasone 2 Calcium Dobesilate 2 Anastrozole 2 prucalopride 1 peppermint oil 1 penclomedine 1 pegfilgrastim 1 oxycodone-acetaminophen 1 methylnaltrexone 1 linaclotide 1 licogliflozin 1 kang-lai-te 1 isatuximab 1 exemestane 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04499950 2025-03-06

A-NEW

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed

53 enrolled 14 charts

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡